Food and Drug Administration
September 30, 2003
Slides
Trial Design Issues in SLE, Joel Schiffenbauer, FDA (HTM) (PPT)
Steroid-Sparing Ability of Agents in SLE, Dr. Matthew Liang, MD, FDA (HTM) (PPT)